Edayan, Cesar M.
HRN: 26-09-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/31/2024
11/07/2024
IV
500mg
Q6
S/P ORIF Tibia
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes